Browsing: pharmaceutical investing
The commitment to advancing the development of bexicaserin for patients with Developmental and Epileptic Encephalopathies (DEEs) is emphasized by Dr.…
Approximately one-third of the total pharmaceutical company campaign contributions can be attributed to the top three donors: Pfizer, Merck, and…
Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies…
Cardiol Therapeutics is a clinical-stage life sciences company focused on researching and developing anti-inflammatory and anti-fibrotic therapies for heart disease…
The positive tumour response observed in the sixth patient has resulted in the initiation of additional recruitment for the ongoing…
The FDA has granted Fast Track Designation to Narmafotinib for the treatment of advanced pancreatic cancer. This designation is intended…
BCAL has initiated operations in the United States, expanding its presence into the American market.
In discussing the complexities of IgA nephropathy, Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University…
Professor Dana Rizk, an Investigator and member of the APPLAUSE-IgAN Steering Committee, as well as a professor at the University…
In a statement by Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at…